JURIS : LAW TITLES Flashcards
1
Q
RA 10918
A
Philippine Pharmacy Act
2
Q
RA 10912
A
Continuing Professional Development Act of 2016
3
Q
RA 10909
A
No Shortchanging Act of 2016
4
Q
RA 5921
A
The Pharmacy Law
5
Q
RA 3720
A
Food, Drugs, Devices, and Cosmetics Act
6
Q
RA 6425
A
Dangerous Drug Act of 1972
7
Q
RA 6675
A
The Generics Act of 1988
8
Q
RA 9165
A
Comprehensive Dangerous Act of 2002
9
Q
RA 7432
A
The Senior Citizens Act
10
Q
RA 9257
A
Expanded Senior Citizens Act
11
Q
RA 9994
A
Expanded Senior Citizens Act of 2010
12
Q
RA 8203
A
Special Law on Counterfeit Drug
13
Q
RA 8981
A
PRC Modernization Act
14
Q
RA 7581
A
The Price Act of 2000
15
Q
RA 7394
A
The Consumers Act of the Philippines
16
Q
RA 9711
A
Food and Drug Administration Act of 2009
17
Q
RA 9502
A
Universal Cheaper and Quality Medicines Act of 2008
18
Q
RA 8293
A
Intellectual Property Code of the Philippines
19
Q
RA 8172
A
ASIN Law
20
Q
RA 9211
A
Tobacco Regulation Act of 2009
21
Q
RA 7876
A
The Senior Citizens Center Act
22
Q
RA 8423
A
TAMA of 1997
23
Q
RA 9184
A
Procurement Act
24
Q
RA 8976
A
Food Fortification Law
25
RA 10354
The Responsible Parenthood and Reproductive Health Act of 2012
26
EO 174
Latest Amendments on RA 5921
27
AO 2014-0034
Rules and Regulations on the Licensing of Establishments Engaged in the Manufacture, Conduct of Clinical Trials, Distribution, Importation, Exportation and Retailing of Drug Products and Issuances of Other Related Authorization
28
AO 2014-025
Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drugstore/Pharmacy/Botica and Other Similar Outlets following AO 2014-0034 (Oct 13,2014)
29
AO 2014-026
Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Distributors following AO 2014-0034 (Oct 13,2014)
30
AO 2014-027
Guidelines on the Implementation of New Rules and Regulations on the Licensing of Retail Outlets for Non-Prescription Drugs (RONPDs) following AO 2014-0034 (Oct 13,2014)
31
AO 2014-028
Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Manufacturers following AO 2014-0034 (Oct 13,2014)
32
AO 2016-0003
Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration (FDA)
33
AO 2016-0008
Revised Rules and Regulations Governing the Generic Labeling Requirements of Drug Products for Human Use
34
AO 2015-0053
Implementing Guidelines on the Promotion and Marketing of Prescription Pharmaceutical Products and Medical Devices
35
AO 2015-0026
Rules and Regulation of Veterinary Drugs and Products, Veterinary Biological Products, and Veterinary Drugs Establishments
36
AO 42
Formulation and Implementation of a national Plan to Combat Antimicrobial Resistance in the Philippines
37
AO 2011-0009
National Policy and Program on Pharmacovigilance
38
EO 175
Latest Amendments on RA 3720
39
EO 851
Creation of BFAD
40
RA 10911
Anti-Age Discrimination in Employment Act
41
EO 266
Institutionalization of CPE
42
EO 302
Adoption of the Philippine Pharmacopeia as the Official Bood of Standards Reference for the Pharmaceutical Products and Crude Drugs in the Philippines
43
EO 49
Directing the Mandatory Use of PNDF Vol. I as the Basis for Procurement of Drug Products by the Government
44
EO 119
Reorganization of BFAD
45
PD 1926
Shortens the Pharmacy from 5 years to 4 years
46
PD 1363
Candidacy for Pharmacy Board Examination (Citizenship Requirement)
47
PD 881
Household Hazardous Substance Act
48
PD 223
Creation of PRC
49
AO 220
cGMP
50
AO 43
Practice Guideline for Drugs
51
AO 79
Transitional Remedial Labeling
52
AO 42
Drug Registration of Herbal/Traditional (Local and Imported)
53
AO 55
Requirements for Labeling Materials of Pharmaceutical Products
54
AO 64
Amendments of AO 55
55
AO 67
Revised Rules and Regulations of Registration of Pharmaceutical Products
56
AO 56
Revised Rules and Regulations of Registration of Pharmaceutical Products
57
AO 63
IRR for Dispensing Requirements (RA 6675)
58
AO 62
IRR for Prescribing Requirements (RA 6675)
59
AO 90
Amendments of AO 62
60
RA 11525
An Act Establishing the corona virus disease 2019 (COVID 19) vaccination program expediting the vaccine procurement and administration process
61
RA 11494
An act providing for covid 19 response and recovery for interventions and providing mechanisms accelerated recovery and bolstered the resiliency of the Philippines country
62
RA 10640
An act to further strengthen the anti-drug campaign of the government, amending for the purpose section 21 of RA 9165, otherwise known as the "Comprehensive Dangerous Drug Act of 2002"
63
RA 10354
An act providing for a national policy on responsible parenthood and reproductive health
64
RA 11036
An act establishing a national mental health policy
65
RA 10754
An act expanding the benefits and privileges of PWD
66
RA 11223
An act instituting universal healthcare for all Filipinos, prescribing reforms in the Healthcare system
67
RA 10767
Comprehensive Tuberculosis Elimination Plan Act of 2016
68
RA 10747
An act promulgating a comprehensive policy in addressing the needs of persons with rare disease ("Rare Disease Act of the Philippines")
69
RA 9511
Philippine Technology Transfer Act
70
RA 10643
Graphic Health Warnings Law
71
RA 10932
AN ACT PROHIBITING THE DEMAND OF DEPOSITS OR ADVANCE PAYMENTS FOR THE CONFINEMENT OR TREATMENT OF PATIENTS IN HOSPITALS AND MEDICAL CLINICS IN CERTAIN CASES
72
RA 11215
National Integrated Cancer Control Act
